C Louwrens Braal
7PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 28, 2025
Under-reporting of Validation Efforts for Health Economic Models Persists Despite the Availability of Validation Tools: A Systematic Review.Katharina Abraham, Isaac Corro Ramos, C Louwrens Braal
|Jul 16, 2022
Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trial.C Louwrens Braal, Justin D Westenberg, Sanne M Buijs
|Jun 11, 2022
Tamoxifen use and potential effects on liver parenchyma: A long-term prospective transient elastographic evaluation.C Louwrens Braal, Robert J de Knegt, Agnes Jager
|Jan 12, 2022
Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM Trial.C Louwrens Braal, Anne Kleijburg, Agnes Jager
|Nov 17, 2021
Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing: Feasible in Patients with Hormone-Sensitive Breast Cancer.C Louwrens Braal, Agnes Jager, Esther Oomen-de Hoop
|Aug 18, 2020
Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen.C Louwrens Braal, Koen G A M Hussaarts, Lieke Seuren
Pageof 2
